Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Hansen

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Trials|December 6, 2013
"läuft."--a school-based multi-component program to establish a physically active lifestyle in adolescence: study protocol for a cluster-randomized controlled trialVivien Suchert, Barbara Isensee, Julia Hansen, et al.
The Journal of Clinical Investigation|October 1, 2019
Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosisEduardo Beltrán, Lisa Ann Gerdes, Julia Hansen, et al.
Frontiers in Immunology|December 21, 2023
Mouse models of diffuse large B cell lymphomaAreya Tabatabai, Aastha Arora, Svenja Höfmann, et al.
Plos One|July 15, 2022
Lipobiotin-capture magnetic bead assay for isolation, enrichment and detection of Mycobacterium tuberculosis from salivaJulia Hansen, Katharina Kolbe, Inke R König, et al.
Blood|July 19, 2023
MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8Elisa Mandato, Qingsheng Yan, Jing Ouyang, et al.
The EMBO Journal|November 20, 2024
ZBTB48 is a priming factor regulating B-cell-specific CIITA expressionGrishma Rane, Vivian L S Kuan, Suman Wang, et al.
Blood Advances|December 7, 2023
An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphomaRuth Flümann, Julia Hansen, Jörn Meinel, et al.
Cancer Discovery|October 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasLeandro Venturutti, Martin A Rivas, Benedikt W Pelzer, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Trials|December 6, 2013
"läuft."--a school-based multi-component program to establish a physically active lifestyle in adolescence: study protocol for a cluster-randomized controlled trialVivien Suchert, Barbara Isensee, Julia Hansen, et al.
The Journal of Clinical Investigation|October 1, 2019
Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosisEduardo Beltrán, Lisa Ann Gerdes, Julia Hansen, et al.
Frontiers in Immunology|December 21, 2023
Mouse models of diffuse large B cell lymphomaAreya Tabatabai, Aastha Arora, Svenja Höfmann, et al.
Plos One|July 15, 2022
Lipobiotin-capture magnetic bead assay for isolation, enrichment and detection of Mycobacterium tuberculosis from salivaJulia Hansen, Katharina Kolbe, Inke R König, et al.
Blood|July 19, 2023
MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8Elisa Mandato, Qingsheng Yan, Jing Ouyang, et al.
The EMBO Journal|November 20, 2024
ZBTB48 is a priming factor regulating B-cell-specific CIITA expressionGrishma Rane, Vivian L S Kuan, Suman Wang, et al.
Blood Advances|December 7, 2023
An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphomaRuth Flümann, Julia Hansen, Jörn Meinel, et al.
Cancer Discovery|October 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasLeandro Venturutti, Martin A Rivas, Benedikt W Pelzer, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Pageof 5